![Jeff Jonas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Jonas
Direttore/Membro del Consiglio presso
COMPASS PATHWAYS PLC
Patrimonio netto: - $ in data 31/05/2026
Profilo
Jeffrey M. Jonas ha fondato AVAX Technologies, Inc. ed Evogen, Inc. È direttore e responsabile dell'innovazione di SAGE Therapeutics, Inc. Il Dr. Jonas è anche nel consiglio di Pharmaceutical Research & Manufacturers of America, Karuna Therapeutics, Inc. e Generation Bio Co. In precedenza ha ricoperto la posizione di presidente, presidente e amministratore delegato di Evogen, Inc., presidente, amministratore delegato e direttore di AVAX Technologies, Inc., vicepresidente della ricerca e dello sviluppo clinico di Upjohn Laboratories LLC, vicepresidente esecutivo di Ionis Pharmaceuticals, Inc., presidente di Shire Regenerative Medicine, Inc., direttore medico e vicepresidente esecutivo di Forest Laboratories, Inc., presidente della divisione medicina rigenerativa di Shire Plc, capo specializzando del McLean Hospital, Inc. e capo specializzando della Harvard Medical School. Si è laureato all'Amherst College e ha conseguito il dottorato alla Harvard Medical School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
COMPASS PATHWAYS PLC -.--% | 27/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Jeff Jonas
| Società | Posizione | Inizio |
|---|---|---|
| COMPASS PATHWAYS PLC | Direttore/Membro del Consiglio | 29/10/2025 |
Ryne Biotechnology, Inc.
 Ryne Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for neuron replacement therapies for neurological conditions | Presidente | 01/02/2024 |
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Investitore di Private Equity | 01/01/2024 |
Angiocrine Bioscience, Inc.
 Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage cell and gene therapy company | Direttore/Membro del Consiglio | - |
Noema Pharma AG
 Noema Pharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that provide therapeutics for central nervous system | Presidente | 04/10/2021 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jeff Jonas
| Società | Posizione | Fine |
|---|---|---|
| GENERATION BIO CO. | Direttore/Membro del Consiglio | 06/02/2026 |
| SAGE THERAPEUTICS, INC. | Amministratore Delegato | 15/12/2020 |
| KARA THER | Direttore/Membro del Consiglio | 18/03/2024 |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Jeff Jonas
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
55
Relazioni di 1° grado
24
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 24 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
AVAX Technologies, Inc.
 AVAX Technologies, Inc. BiotechnologyHealth Technology Operates as development stage company with interest in the development and future commercialization of individualized cancer vaccines | Health Technology |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Shire Regenerative Medicine, Inc.
 Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Manufactures biomedical products | Health Technology |
CARA Therapeutics, Inc.
 CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed | Health Technology |
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage cell and gene therapy company | Commercial Services |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McLean Hospital, Inc.
 McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Evogen, Inc.
 Evogen, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops technology for biological and chemical defense systems | Electronic Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Upjohn Laboratories LLC | |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
PureTech Health Plc
 PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
Compass Pathways Plc
 Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Finance |
Noema Pharma AG
Noema Pharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that provide therapeutics for central nervous system | Commercial Services |
Ryne Biotechnology, Inc.
Ryne Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for neuron replacement therapies for neurological conditions | Health Technology |
Abio-X Holdings, Inc. |
